Document Detail

Issues and controversies in venous thromboembolism.
MedLine Citation:
PMID:  9988957     Owner:  NLM     Status:  MEDLINE    
This paper gives specific recommendations on a number of issues in venous thromboembolism: how to evaluate idiopathic deep vein thrombosis (DVT); how to treat calf vein thrombosis and upper-extremity DVT; how to use low-molecular-weight heparin, vena cava filters, catheter-directed thrombolytic therapy, and compression stockings; how long to continue anticoagulation therapy; and how to manage recurrent DVT.
T L Carman; B B Fernandez
Related Documents :
10102457 - Is the prevalence of the factor v leiden mutation in patients with pulmonary embolism a...
6711637 - The natural history of postoperative venous thromboemboli in gynecologic oncology: a pr...
2118037 - Doppler ultrasonic diagnosis for deep venous thrombosis of lower limbs.
9798437 - Thromboprophylaxis in hip arthroplasty. new frontiers and future strategy.
16911577 - Ablation of atrial fibrillation in humans using a balloon-based ablation system: identi...
732977 - Eight-year follow-up of experimental carotid-middle cerebral and carotid-basilar arteri...
Publication Detail:
Type:  Comparative Study; Journal Article; Review    
Journal Detail:
Title:  Cleveland Clinic journal of medicine     Volume:  66     ISSN:  0891-1150     ISO Abbreviation:  Cleve Clin J Med     Publication Date:  1999 Feb 
Date Detail:
Created Date:  1999-03-02     Completed Date:  1999-03-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8703441     Medline TA:  Cleve Clin J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  113-23     Citation Subset:  IM    
Department of Internal Medicine, Cleveland Clinic, Florida, Fort Lauderdale, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticoagulants / therapeutic use
Arm / blood supply
Blood Coagulation Disorders / complications
Fibrinolytic Agents / therapeutic use
Heparin, Low-Molecular-Weight / therapeutic use
Neoplasms / complications
Thrombolytic Therapy
Thrombophlebitis / drug therapy
Vena Cava Filters
Venous Thrombosis* / diagnosis,  etiology,  therapy
Reg. No./Substance:
0/Anticoagulants; 0/Fibrinolytic Agents; 0/Heparin, Low-Molecular-Weight
Comment In:
Cleve Clin J Med. 1999 Nov-Dec;66(10):584   [PMID:  10598360 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aggressive blood pressure lowering is safe, but benefit is still hard to prove.
Next Document:  Development of a computerized database for evaluation of nurse practitioner student clinical experie...